Assessing therapeutic decisions in generalized myasthenia gravis

Background The therapeutic landscape in generalized myasthenia gravis (gMG) has been continuously evolving in recent years, with over five products approved, each with different efficacy, safety, and administration profiles. With the availability of new targeted treatments, physicians are faced with...

Descripción completa

Detalles Bibliográficos
Autores: Gutiérrez-Gutiérrez, Gerardo, Gómez-Ballesteros, R.|||0000-0001-9582-9230, Sotoca Fernández, Javier|||0000-0003-3400-1434, Ares, A., Villaverde, R., Reyes-Garrido, Virginia, Armangué, T., Salas, Eduardo|||0000-0002-6837-2471, Díaz-Abós, P., Rebollo, P., Sarmiento, M., Escobar, I., Maurino, Jorge|||0000-0001-9858-3555, Querol, Luis|||0000-0002-4289-8264
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:322603
Acceso en línea:https://ddd.uab.cat/record/322603
https://dx.doi.org/urn:doi:10.1371/journal.pone.0322168
Access Level:acceso abierto
Palabra clave:Adult
Clinical Decision-Making
Cross-Sectional Studies
Decision Making
Female
Humans
Male
Myasthenia Gravis
Neurologists
Surveys and Questionnaires
id ES_d18a70fe4e14a44906648e329014e5e6
oai_identifier_str oai:ddd.uab.cat:322603
network_acronym_str ES
network_name_str España
repository_id_str
spelling Assessing therapeutic decisions in generalized myasthenia gravisStudy protocolGutiérrez-Gutiérrez, GerardoGómez-Ballesteros, R.|||0000-0001-9582-9230Sotoca Fernández, Javier|||0000-0003-3400-1434Ares, A.Villaverde, R.Reyes-Garrido, VirginiaArmangué, T.Salas, Eduardo|||0000-0002-6837-2471Díaz-Abós, P.Rebollo, P.Sarmiento, M.Escobar, I.Maurino, Jorge|||0000-0001-9858-3555Querol, Luis|||0000-0002-4289-8264AdultClinical Decision-MakingCross-Sectional StudiesDecision MakingFemaleHumansMaleMyasthenia GravisNeurologistsSurveys and QuestionnairesBackground The therapeutic landscape in generalized myasthenia gravis (gMG) has been continuously evolving in recent years, with over five products approved, each with different efficacy, safety, and administration profiles. With the availability of new targeted treatments, physicians are faced with the challenge of therapeutic decision-making tailored to traditional therapeutic goals, individual preferences, and personal experience, seeking optimal disease control with a positive safety profile. In this context of uncertainty and multiple novel choices, this study aims to provide insights into the preferred treatment choices of neurologists managing gMG and to identify demographic, professional or behavioral factors influencing the decision-making process. Methods This is a non-interventional, cross-sectional, web-based study involving 150 neurologists treating gMG patients in collaboration with the Spanish Society of Neurology. The primary endpoint will be to assess preferences for different gMG treatment attributes using a conjoint analysis to create hypothetical treatment scenarios. Therapeutic inertia, described as the lack of treatment initiation or intensification when therapeutic goals are not met, will be evaluated as a secondary endpoint through 7 case scenarios simulating real gMG clinical practice situations. Neurologists will also answer a survey composed of demographic, professional, and behavioral characteristics (user resistance behavior, care-related regret, burnout, risk attitude, empathy, work fulfilment, and personality traits) to recognize possible factors influencing decisions. Conclusions The study findings will contribute to better understanding of decision-making in gMG under a changing therapeutic landscape with multiple new targeted options, and will identify which factors have a role in affecting those decisions.Universitat Autònoma de Barcelona. Departament de Medicina 22025-01-0120252025-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/322603https://dx.doi.org/urn:doi:10.1371/journal.pone.0322168reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:3226032026-06-06T12:50:31Z
dc.title.none.fl_str_mv Assessing therapeutic decisions in generalized myasthenia gravis
Study protocol
title Assessing therapeutic decisions in generalized myasthenia gravis
spellingShingle Assessing therapeutic decisions in generalized myasthenia gravis
Gutiérrez-Gutiérrez, Gerardo
Adult
Clinical Decision-Making
Cross-Sectional Studies
Decision Making
Female
Humans
Male
Myasthenia Gravis
Neurologists
Surveys and Questionnaires
title_short Assessing therapeutic decisions in generalized myasthenia gravis
title_full Assessing therapeutic decisions in generalized myasthenia gravis
title_fullStr Assessing therapeutic decisions in generalized myasthenia gravis
title_full_unstemmed Assessing therapeutic decisions in generalized myasthenia gravis
title_sort Assessing therapeutic decisions in generalized myasthenia gravis
dc.creator.none.fl_str_mv Gutiérrez-Gutiérrez, Gerardo
Gómez-Ballesteros, R.|||0000-0001-9582-9230
Sotoca Fernández, Javier|||0000-0003-3400-1434
Ares, A.
Villaverde, R.
Reyes-Garrido, Virginia
Armangué, T.
Salas, Eduardo|||0000-0002-6837-2471
Díaz-Abós, P.
Rebollo, P.
Sarmiento, M.
Escobar, I.
Maurino, Jorge|||0000-0001-9858-3555
Querol, Luis|||0000-0002-4289-8264
author Gutiérrez-Gutiérrez, Gerardo
author_facet Gutiérrez-Gutiérrez, Gerardo
Gómez-Ballesteros, R.|||0000-0001-9582-9230
Sotoca Fernández, Javier|||0000-0003-3400-1434
Ares, A.
Villaverde, R.
Reyes-Garrido, Virginia
Armangué, T.
Salas, Eduardo|||0000-0002-6837-2471
Díaz-Abós, P.
Rebollo, P.
Sarmiento, M.
Escobar, I.
Maurino, Jorge|||0000-0001-9858-3555
Querol, Luis|||0000-0002-4289-8264
author_role author
author2 Gómez-Ballesteros, R.|||0000-0001-9582-9230
Sotoca Fernández, Javier|||0000-0003-3400-1434
Ares, A.
Villaverde, R.
Reyes-Garrido, Virginia
Armangué, T.
Salas, Eduardo|||0000-0002-6837-2471
Díaz-Abós, P.
Rebollo, P.
Sarmiento, M.
Escobar, I.
Maurino, Jorge|||0000-0001-9858-3555
Querol, Luis|||0000-0002-4289-8264
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona. Departament de Medicina
dc.subject.none.fl_str_mv Adult
Clinical Decision-Making
Cross-Sectional Studies
Decision Making
Female
Humans
Male
Myasthenia Gravis
Neurologists
Surveys and Questionnaires
topic Adult
Clinical Decision-Making
Cross-Sectional Studies
Decision Making
Female
Humans
Male
Myasthenia Gravis
Neurologists
Surveys and Questionnaires
description Background The therapeutic landscape in generalized myasthenia gravis (gMG) has been continuously evolving in recent years, with over five products approved, each with different efficacy, safety, and administration profiles. With the availability of new targeted treatments, physicians are faced with the challenge of therapeutic decision-making tailored to traditional therapeutic goals, individual preferences, and personal experience, seeking optimal disease control with a positive safety profile. In this context of uncertainty and multiple novel choices, this study aims to provide insights into the preferred treatment choices of neurologists managing gMG and to identify demographic, professional or behavioral factors influencing the decision-making process. Methods This is a non-interventional, cross-sectional, web-based study involving 150 neurologists treating gMG patients in collaboration with the Spanish Society of Neurology. The primary endpoint will be to assess preferences for different gMG treatment attributes using a conjoint analysis to create hypothetical treatment scenarios. Therapeutic inertia, described as the lack of treatment initiation or intensification when therapeutic goals are not met, will be evaluated as a secondary endpoint through 7 case scenarios simulating real gMG clinical practice situations. Neurologists will also answer a survey composed of demographic, professional, and behavioral characteristics (user resistance behavior, care-related regret, burnout, risk attitude, empathy, work fulfilment, and personality traits) to recognize possible factors influencing decisions. Conclusions The study findings will contribute to better understanding of decision-making in gMG under a changing therapeutic landscape with multiple new targeted options, and will identify which factors have a role in affecting those decisions.
publishDate 2025
dc.date.none.fl_str_mv 2
2025-01-01
2025
2025-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/322603
https://dx.doi.org/urn:doi:10.1371/journal.pone.0322168
url https://ddd.uab.cat/record/322603
https://dx.doi.org/urn:doi:10.1371/journal.pone.0322168
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869420271936471040
score 15,812429